Patent №
US 8,100,533
Granted
2012-01-24
Filed 2009
Owner
DIOPSYS, INC.
Lab
—
AI components
2
vision · planning
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
12435678
A pattern VEP system for screening for glaucoma and other optic nerve related diseases/deficiencies. The system combines high contrast and low contrast testing. The low contrast testing allows for highly sensitive glaucoma testing and the high contrast allows for a sensitive test of the central vision. The system also includes a narrowly tailored method of rejecting corrupted data allowing the system to selectively salvage useful portions of a signal. The system also provides a method of data modeling to locate the N75-P100-N135 complex in a waveform and determine if it falls within the normal range.
AI classification
Ownership
DIOPSYS, INC.
assignment · 230950252
Assignors
DERR, PETER H., EMMER, MATT
On an employer assignment, the assignors are typically the inventors.